Authors: Spielmann, M Llombart-Cussac, A Kalla, S Espie, M Namer, M Ferrero, JM Dieras, V Fumoleau, P Cuvier, C Perrocheau, G Ponzio, A Kayitalire, L Pouillart, P

Citation: M. Spielmann et al., Single-agent gemcitabine is active in previously treated metastatic breastcancer, ONCOL-BASEL, 60(4), 2001, pp. 303-307

Authors: Cottu, PH Extra, JM Espie, M Marolleau, J de Roquancourt, A Makke, J Miclea, JM Laurence, V Mayeur, D Lerebours, F Cuvier, C Marty, M

Citation: Ph. Cottu et al., High-dose sequential epirubicin and cyclophosphamide with peripheral bloodstem cell support for advanced breast cancer: results of a phase II study, BR J CANC, 85(9), 2001, pp. 1240-1246

Authors: Wasserman, E Cuvier, C Lokiec, F Goldwasser, F Kalla, S Mery-Mignard, D Ouldkaci, M Besmaine, A Dupont-Andre, G Mahjoubi, M Marty, M Misset, JL Cvitkovic, E

Citation: E. Wasserman et al., Combination of oxaliplatin plus irinotecan in patients with gastrointestinal tumors: Results of two independent phase I studies with pharmacokinetics, J CL ONCOL, 17(6), 1999, pp. 1751-1759

Authors: Marty, M Espie, M Cottu, PH Cuvier, C Lerebours, F

Citation: M. Marty et al., Optimizing chemotherapy for patients with advanced breast cancer, ONCOL-BASEL, 57, 1999, pp. 21-26

Authors: Cuvier, C

Citation: C. Cuvier, Radio uproar (Market testing), DOWN BEAT, 66(5), 1999, pp. 10-10

Authors: Cottu, PH Cuvier, C Espie, M Marty, M

Citation: Ph. Cottu et al., Iatrogenic neuropathic pain in oncology, EUROCANCER 98, 1998, pp. 221-224